Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Journal metrics

Journal metrics

Metrics and turnaround details

First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

Scopus

Scopus profile

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
In Press Original full research article

Enhanced Wound Healing with Engineered Dermal Tissues: Collagen-Based Scaffolds Enriched with Chitosan, Multi-walled Carbon Nanotubes, and Angiotensin II

Published
2026-05-18
Full text

Keywords

  • Engineered tissues
  • regenerative medicine
  • chronic wounds
  • multi-walled carbon nanotubes
  • wound healing
  • nanomedicine

Abstract

Chronic wounds represent significant health challenges due to the complex, multistep nature of wound healing, which involves numerous key factors. Effective wound healing is not all about wound closure but also about restoring the skin's normal texture, appearance, and function. Engineered skin substitutes have emerged as a potential treatment. This project developed novel engineered dermis tissues (EDTs) using collagen-based scaffolds enriched with chitosan, multi-walled carbon nanotubes (MWCNTs), and angiotensin II (Ang II) to enhance wound healing. These EDTs were tested in a mouse full-thickness wound model and evaluated macroscopically and histologically after 14 days. Results showed that all transplanted EDTs significantly reduced wound contraction and increased epithelialization, especially those containing Ang II. The transplanted EDTs did not affect wound closure or the thickness of the new epidermis or dermis. Overall, our EDTs improved wound healing quality by promoting epithelialization and reducing contraction.

Article history

Received
2025-12-01
Accepted
2026-04-11
Available online
2026-05-18
قيد النشر بحث أصيل كامل

Enhanced Wound Healing with Engineered Dermal Tissues: Collagen-Based Scaffolds Enriched with Chitosan, Multi-walled Carbon Nanotubes, and Angiotensin II

Published
2026-05-18
البحث كاملا

الكلمات الإفتتاحية

  • Engineered tissues
  • regenerative medicine
  • chronic wounds
  • multi-walled carbon nanotubes
  • wound healing
  • nanomedicine

الملخص

Chronic wounds represent significant health challenges due to the complex, multistep nature of wound healing, which involves numerous key factors. Effective wound healing is not all about wound closure but also about restoring the skin's normal texture, appearance, and function. Engineered skin substitutes have emerged as a potential treatment. This project developed novel engineered dermis tissues (EDTs) using collagen-based scaffolds enriched with chitosan, multi-walled carbon nanotubes (MWCNTs), and angiotensin II (Ang II) to enhance wound healing. These EDTs were tested in a mouse full-thickness wound model and evaluated macroscopically and histologically after 14 days. Results showed that all transplanted EDTs significantly reduced wound contraction and increased epithelialization, especially those containing Ang II. The transplanted EDTs did not affect wound closure or the thickness of the new epidermis or dermis. Overall, our EDTs improved wound healing quality by promoting epithelialization and reducing contraction.

Article history

تاريخ التسليم
2025-12-01
تاريخ القبول
2026-04-11
Available online
2026-05-18